MENU
CGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Compugen (CGEN) Ownership - Who owns Compugen?
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
68
Web
https://www.cgen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
131.6M
P/E Ratio
64.00
Total Cash
103.26M
Projected Growth
N/A
Total Debt
2.91M
Revenue
27.86M
Risk (Beta)
3.30
Dividend Yield
N/A
Total Cash/Share
1.10
Total Debt/Equity
N/A
Revenue/Share
0.31 USD as % of share price
Fundamentals
CGEN
Capitalization
132M
P/E Ratio
64.00
Risk (Beta)
3.30
Dividend Yield
N/A
Total Cash
103M
Total Cash/Share
1.10
Total Debt
2.91M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.31%
Revenue
27.9M
ROE
N/A
Book Value
54.9M
P/B Ratio
2.45
Cash Flow
N/A
Earnings
-0.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
248K
Current Ratio
5.26
Current Revenue Per Employee
19878.38
Dividends Per Share - Security
N/A
EBITDA
-14.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
54.11
Revenue To Assets
-12.04
Shares Held By Institutions
10M
Shares Outstanding - Current
93.5M
Total Liabilities
60.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
-5.882
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a maker of drug and diagnostics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
68
Web
https://www.cgen.com